Anti-CLDN8 antibody (29-81) (STJ116680)

SKU:
STJ116680

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-CLDN8 (29-81) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: CLDN8
Gene ID: 9073
Uniprot ID: CLD8_HUMAN
Immunogen Region: 29-81
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 29-81 of human CLDN8 (NP_955360.1).
Immunogen Sequence: QWRVSAFIENNIVVFENFWE GLWMNCVRQANIRMQCKIYD SLLALSPDLQAAR
Tissue Specificity Expressed in the epididymis, mainly in the caput segment.
Post Translational Modifications Ubiquitinated by the BCR(KLHL3) E3 ubiquitin ligase complex in the kidney, leading to its degradation.
Function Tight-junction protein required for paracellular chloride transport in the kidney. Mediates recruitment of CLDN4 to tight junction in the kidney. Claudins play a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity.
Protein Name Claudin-8
Database Links Reactome: R-HSA-420029
Cellular Localisation Cell Junction
Tight Junction
Cell Membrane
Multi-Pass Membrane Protein
Localizes To Tight Junctions In All 3 Segments Of The Epididymis
In The Caput Found In The Lateral Margins Of Principal Cells
And In The Corpus At The Interface Between Basal And Principal Cells
Alternative Antibody Names Anti-Claudin-8 antibody
Anti-CLDN8 antibody
Anti-UNQ779 antibody
Anti-PRO1573 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance